Innoviva
INVA
#5222
Rank
โ‚น155.00 B
Marketcap
โ‚น2,100
Share price
-0.77%
Change (1 day)
32.04%
Change (1 year)

Revenue for Innoviva (INVA)

Revenue in 2025 (TTM): โ‚น36.03 Billion

According to Innoviva's latest financial reports the company's current revenue (TTM ) is โ‚น39.62 Billion. an increase over the revenue in the year 2024 that were of โ‚น30.77 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Innoviva from 2005 to 2025

Annual revenue

Year Revenue Change
2025 โ‚น36.92 B19.99%
2024 โ‚น30.77 B19.06%
2023 โ‚น25.84 B-5.74%
2022 โ‚น27.41 B-6%
2021 โ‚น29.16 B18.42%
2020 โ‚น24.63 B32.33%
2019 โ‚น18.61 B1.99%
2018 โ‚น18.25 B31.58%
2017 โ‚น13.86 B52.8%
2016 โ‚น9.07 B153.17%
2015 โ‚น3.58 B570.8%
2014 โ‚น0.53 B82.94%
2013 โ‚น0.29 B-96.07%
2012 โ‚น7.43 B473.22%
2011 โ‚น1.29 B19.47%
2010 โ‚น1.08 B-4.03%
2009 โ‚น1.13 B1.88%
2008 โ‚น1.11 B28.56%
2007 โ‚น0.86 B-0.47%
2006 โ‚น0.86 B59.93%
2005 โ‚น0.54 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
OPKO Health
OPK
โ‚น61.85 B 56.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
โ‚น21.77 M-99.95%๐Ÿ‡บ๐Ÿ‡ธ USA